CD8A and neoplasm: Previous studies demonstrated that Glycyrrhizic acid, a key component of YGYZ, could suppress neutrophil extracellular trap formation, enhancing CD8+ T cell-mediated tumor cytotoxicity and reducing CRC progression (Chen et al., 2025).